Stem Cell Therapy Market Size to Surpass USD 921.12 Million with CAGR of 17.3% by 2030, Share, Growth, Demand, Global Trends and Competitive Outlook

Data Bridge Market Research analyses that the stem cell therapy market, which is USD 257 million in 2022, is expected to reach USD 921.12 million by 2030, at a CAGR of 17.3% during the forecast period 2023 to 2030

| Source: Data Bridge Market Research Data Bridge Market Research

MELBOURNE, Feb. 23, 2023 (GLOBE NEWSWIRE) -- Data Bridge Market Research completed a qualitative study titled "Stem Cell Therapy Market" with 100+ market data tables, pie charts, graphs, and figures spread across Pages and an easy-to-grasp full analysis. The competitive landscape section of the dependable Stem Cell Therapy market report gives a clear insight into the market share analysis of key industry players. The company profiles of all the major market players and brands that are dominating the Stem Cell Therapy market with moves like product launches, joint ventures, merges, and accusations which in turn is affecting the sales, import, export, revenue, and CAGR values have been cited in the report. The study consists of a market attractiveness analysis, wherein each segment is benchmarked based on its market size, growth rate, and general attractiveness. The Stem Cell Therapy market research report brings into light key market dynamics of the sector.

The Stem Cell Therapy market report contains the drivers and restraints for the market that are derived from SWOT analysis, and also shows what all the recent developments, product launches, joint ventures, mergers, and acquisitions by the several key players and brands that are driving the market are by systemic company profiles. The report is based on the market type, organization size, availability on-premises and the end-users organization type, and the availability in areas such as North America, South America, Europe, Asia-Pacific, and Middle East & Africa. The company profiles of all the key players and brands that are dominating the Stem Cell Therapy market have been taken into consideration here.

Data Bridge Market Research analyses that the stem cell therapy market, which is USD 257 million in 2022, is expected to reach USD 921.12 million by 2030, at a CAGR of 17.3% during the forecast period 2023 to 2030. In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.

Download a PDF Sample of the Stem Cell Therapy Market @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-stem-cell-therapy-market

Stem cell therapy is regenerative medicinal therapy used to repair damaged cells by lowering inflammation and controlling the immune system. This makes stem cell therapy an effective remedy for several illnesses. Studies on stem cell therapies for Crohn's disease, Multiple Sclerosis, Lupus, COPD, Parkinson's, ALS, stroke recovery, and more have been undertaken. Stem cell therapies have also been utilized to treat autoimmune, inflammatory, neurological, orthopedic, and traumatic disorders.

The World Health Organization (WHO) estimates cerebrovascular diseases and neurological disorders account for around 7.1% of the global disease burden. As a result, businesses are carrying out fundamental research and preclinical studies to examine stem cells' ability to regenerate in treating neurological diseases. Cellular treatments for cancer are currently receiving significant financing from companies, which is expected to support market expansion.

Recent Developments

  • In 2021, A worldwide licensed agreement and strategic collaboration between Minovia Therapeutics, Ltd. and Astellas Pharma, Inc. was established for the development of cutting-edge stem cell therapy programs for illnesses brought on by mitochondrial malfunction. The partnership intends to accelerate the development of allogeneic mitochondrial cell therapy initiatives. The two businesses will collaborate to investigate potential cell treatment program prospects using Astellas' genetically modified, induced pluripotent stem cells and Minovia's MAT platform technology.

The Global Market Is Analyzed in Depth in the Latest Study. Taking into account the current level of competition and its projected evolution over the next few years.

Rapidly increasing demands, a rise in industrialization, consumer awareness, growing sectors, and technical improvements are fueling the expansion of the global Stem Cell Therapy market. Sales and revenue in this sector have increased at an exponential rate. The market's size and growth are both expected to increase thanks to the factors driving the market's expansion over the projected period.

Leading businesses in the worldwide Stem Cell Therapy market are investing heavily in R&D in order to build a larger client base and expand their share of the market by reintroducing improved products to consumers. All of the companies' strategy, as well as their financial health, revenue, gross margin, and growth rate, are detailed in the study.

Fundamental Aim of Stem Cell Therapy Market Report

In the Stem Cell Therapy market, every company has goals, but this report focus in on the most important ones, allowing you to gain insight into the competition, the future of the market, potential new products, and other useful information that can boost your sales significantly.

  • Major alterations to the Stem Cell Therapy Market in the near future.
  • Notable Market rivals around the world.
  • The Stem Cell Therapy Market's Future Scope and Product Outlook
  • Future-promising emerging markets.
  • The Market Presents Difficult Challenges and Threats.
  • Sales data and profiles of the world's leading Stem Cell Therapy manufacturers

The Stem Cell Therapy Market is Dominated by Firms Such as

  • Athersys Inc. (U.S.)
  • Mesoblast Ltd (Australia)
  • Biorestorative Therapies Inc. (U.S.)
  • Pluristem Inc. (Israel)
  • Brainstorm Cell Limited. (U.S.)
  • ViaCyte Inc. (U.S.)
  • Gamida Cell (U.S.)
  • HOPE BIOSCIENCES (U.S.)
  • Cellular Biomedicine Group (U.S.)
  • Smith+Nephew (U.K.)
  • MEDIPOST (South Korea)
  • ANTEROGEN. C.O., LTD. (South Korea)
  • NuVasive Inc. (U.S.)
  • RTI Surgical (U.S.)
  • AlloSource (U.S.)
  • JCR Pharmaceuticals Co. Ltd. (Japan)
  • Takeda Pharmaceutical Company Limited (Japan)

Download the Complete Research Study Here in PDF Format @ https://www.databridgemarketresearch.com/checkout/buy/enterprise/global-stem-cell-therapy-market

Opportunities for Key Players:

  • An increase in R&D activities will act as an opportunity

Additionally, the increase in R&D activities and rising investments from public and private organizations will open up new possibilities for the market's growth rate. For instance, U.S. healthcare spending increased by 3.4% in 2021, per the Health Care Price Index (HCPI). The rise in growth indicates that federal spending fell sharply the year before, from USD 287,000 million in 2020 to USD 170,000 million in 2021.

The prompt treatment of chronic illnesses has increased the demand for stem cell therapy in the U.S. and Europe. Due to these positive elements, there is a greater need for drugs, and both major and minor market players are employing various techniques to meet this demand.

  • A strategic initiative by market players will widen the scope of growth

The leading companies are also working to develop targeted strategies, including product launches, acquisitions, approvals, expansions, and partnerships, to ensure the smooth operation of the business, minimize risks, and boost the market's long-term growth in sales.

For instance,

To create and market the search-use-only (RUO) microfluidic intracellular delivery technology, ViaCyte, Inc. teamed up with SQZ Biotechnologies in May 2022. Through the agreement, both market participants will be able to share fresh cell engineering research in hematopoietic stem cells using

Key Market Segments Covered in Stem Cell Therapy Industry Research

Product Type

  • Bone Marrow Derived Mesenchymal Cells
  • Placental or Umbilical Stem Cell
  • Adipose Tissue Derived Mesenchymal Stem Cells

 Type

  • Allogenic Stem Cell Therapy
  • Autologous Stem Cell Therapy

Application

  • Musculoskeletal Disorders
  • Acute Graft-Versus-Host Disease (AGVHD)
  • Wounds and Injuries
  • Cardiovascular Diseases
  • Surgeries
  • Gastrointestinal Diseases

 End User

  • Hospitals
  • Surgical Centers
  • Therapeutic Companies
  • Services Companies

 Distribution Channel

  • Direct Tender
  • Third Party Distributors

Key Growth Drivers:

  • The rise in prevalence and incidence of chronic diseases will drive the market growth

The majority of people around the world suffer from chronic ailments. One in three adults worldwide has a chronic illness. Chronic diseases have impacted the health and quality of life of many people. Chronic illnesses, such as cancer, musculoskeletal and neurological conditions, chronic injuries, cardiovascular and gastrointestinal conditions, and cancer, can result in hospitalization, long-term incapacity, a decline in quality of life, and even death.

The mesenchymal stem cells penetrate and integrate into several organs, treat lung, spinal cord, autoimmune disorders, liver, bone, and cartilage diseases, and treat multiple organ damage. Using stem cells in the therapy of inflammatory, immune system, and degenerative tissue illnesses is an effective strategy.

  • The growing need for potent treatments will propel the market growth

One of the key drivers of market expansion is significant R&D investments. In addition, the growing need for potent treatments to reduce disease burden during the forecast period is another factor fuelling the growth. For instance, the 5-year exploratory study on Parkinson's illness by Celavie Biosciences is still ongoing as of May 2020. For the treatment of Parkinson's disease and other illnesses of the central nervous system, the business is developing regenerative stem cell therapies. Ok99 stem cell-based exploratory clinical studies for Parkinson's disease were effective, according to Celavie Biosciences.

Browse a Detailed Summary of the Research Report @ https://www.databridgemarketresearch.com/reports/global-stem-cell-therapy-market

Stem Cell Therapy Market Regional Analysis/Insights:

The countries covered in the stem cell therapy market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

North America dominates the stem cell therapy market because of the region's well-developed healthcare infrastructure and favourable reimbursement policies. Another factor contributing to the region's growth is the number of government initiatives to promote stem cell therapy

Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2023 to 2030, owing to the growing incidence of cancer cases, rising technological advancements, and rising prevalence of chronic diseases such as diabetes, cancer, and neurological disorders.

This Market Intelligence Report Analyses Some of the Most Crucial Concerns:

  • How will the major segments of this international market develop over the next few years?
  • Who are the major players that will dominate the market in the future?
  • When it comes to this industry, who are the top suppliers and producers?
  • How have the most successful companies in the industry planned for future growth and expansion?
  • In what sectors might we expect to see the greatest increase in demand over the coming years?
  • How many distinct subsets of buyers make up this market?
  • Which regional powerhouse do you foresee as becoming the largest player in the international market?
  • Does a new coronavirus pandemic have any consequences?
  • In what ways are established actors stymied by the entry of newcomers, and how may they be overcome?

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Executive Summary
  4. Premium Insights
  5. Global Stem Cell Therapy Market: Regulations
  6. Market Overview
  7. Global Stem Cell Therapy Market, By Product Type
  8. Global Stem Cell Therapy Market, By Type
  9. Global Stem Cell Therapy Market, By Application
  10. Global Stem Cell Therapy Market, By End User
  11. Global Stem Cell Therapy Market, By Distribution Channel
  12. Global Stem Cell Therapy Market, By Region
  13. Global Stem Cell Therapy Market: Company Landscape
  14. SWOT Analyses
  15. Company Profile
  16. Questionnaires
  17. Related Reports

Get the Full Table of Contents @ https://www.databridgemarketresearch.com/toc/?dbmr=global-stem-cell-therapy-market

Explore More Reports:

  • Cancer Stem Cell Therapy Market, By Type (Cell Culturing, Cell Separation, Cell Analysis, Molecular Analysis, Others), Cancer Forms (Breast Cancer, Blood Cancer, Lung Cancer, Brain Cancer, Colorectal Cancer, Pancreatic Cancer, Bladder Cancer, Liver Cancer, Other Cancer), Application (Stem Cell Based Cancer Therapy, Targeted CSCs), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-cancer-stem-cell-therapy-market
  • North America Stem Cell Therapy Market, By Product Type (Bone Marrow Derived Mesenchymal Cells, Placental or Umbilical Stem Cell, Adipose Tissue Derived Mesenchymal Stem Cells, and Others), Type (Allogenic Stem Cell Therapy and Autologous Stem Cell Therapy), Application (Musculoskeletal Disorders, Acute Graft-Versus-Host Disease (AGVHD), Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others), End User (Hospitals and Surgical Centers, Therapeutic Companies, Services Companies, and Others), Distribution Channel (Direct Tender, Third Party Distributors) https://www.databridgemarketresearch.com/reports/north-america-stem-cell-therapy-market
  • Europe Stem Cell Therapy Market, By Product Type (Bone Marrow Derived Mesenchymal Cells, Placental or Umbilical Stem Cell, Adipose Tissue Derived Mesenchymal Stem Cells, and Others), Type (Allogenic Stem Cell Therapy and Autologous Stem Cell Therapy), Application (Musculoskeletal Disorders, Acute Graft-Versus-Host Disease (AGVHD), Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others), End User (Hospitals and Surgical Centers, Therapeutic Companies, Services Companies, and Others), Distribution Channel (Direct Tender, Third Party Distributors) https://www.databridgemarketresearch.com/reports/europe-stem-cell-therapy-market
  • Asia-Pacific Stem Cell Therapy Market, By Product Type (Bone Marrow Derived Mesenchymal Cells, Placental or Umbilical Stem Cell, Adipose Tissue Derived Mesenchymal Stem Cells, and Others), Type (Allogenic Stem Cell Therapy and Autologous Stem Cell Therapy), Application (Musculoskeletal Disorders, Acute Graft-Versus-Host Disease (AGVHD), Wounds and Injuries, Cardiovascular Diseases, Surgeries, Gastrointestinal Diseases, and Others), End User (Hospitals and Surgical Centers, Therapeutic Companies, Services Companies, and Others), Distribution Channel (Direct Tender, Third Party Distributors) https://www.databridgemarketresearch.com/reports/asia-pacific-stem-cell-therapy-market
  • Autologous Stem Cell and Non-Stem Cell Based Therapies Market, By Type (Autologous Stem Cells, Autologous Non-Stem Cells), Product (Blood Pressure (BP) Monitoring Devices, Pulmonary Pressure Monitoring Devices, Intracranial Pressure (ICP) Monitoring Devices), Applications (Neurodegenerative Disorders, Autoimmune Diseases, Cancer and Tumors, Cardiovascular Diseases), End User (Hospitals, Ambulatory Surgical Center), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East and Africa) https://www.databridgemarketresearch.com/reports/global-autologous-stem-cell-and-non-stem-cell-based-therapies-market
  • Cord Stem Cell Banking Market, By Storage Type (Private Banks, Hybrid Banks, Public Banks), Product Type (Cord Blood, Cord Blood, Cord Tissue), Service Type (Collection & Transportation, Processing, Analysis, Storage), Source (Umbilical Cord Blood, Bone Marrow, Peripheral Blood Stem, Menstrual Blood), Indication (Cerebral Palsy, Thalassemia, Leukemia, Diabetes, Autism), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-cord-stem-cell-banking-market
  • Stem Cell Banking Market, By Source (Placental Stem Cells (PSCs), Human Embryo-Derived Stem Cells (hESCs), Bone Marrow-Derived Stem Cells (BMSCs), Dental Pulp-Derived Stem Cells (DPSCS), Adipose Tissue-Derived Stem Cells (ADSCs), Other Stem Cell Sources), Product (Adult Stem Cells, Human Embryonic Cells, IPS Cells), Bank Type (Private, Public), Service Type (Sample Collection and Transportation, Sample Processing, Sample Analysis, Sample Preservation, Storage), Utilization (Used, Unused), Application (Personalized Storage, Clinical, Research) https://www.databridgemarketresearch.com/reports/global-stem-cell-banking-market
  • Induced Pluripotent Stem Cells (iPSCs) Market, By Cell Source  (Skin Cells and Blood Cells), Type (Human IPSCs and Mouse IPSCs), Product (Instruments, Consumables & Kits and Services), Applications (Academic Research, Regenerative Medicine, Cellular Therapy, Toxicology Screening, Drug Discovery and Development, Disease Modelling, Stem Cell Banking, 3D Bio printing and Others), End User (Biotechnology & Pharmaceutical Companies, Research Laboratories, Diagnostic Laboratories and Others), Distribution Channel (Direct Tender and Retail Sales), Country (U.S., Canada, Mexico, Germany, U.K., Italy, France, Spain, Switzerland, Russia, Turkey, Belgium, Netherlands and Rest of Europe, Japan, China, South Korea, India, Australia, Singapore, Thailand, Malaysia, Indonesia, Philippines and Rest of Asia-Pacific, Brazil, Argentina and Rest of South America, South Africa, Egypt, Saudi Arabia, U.A.E, Israel and Rest of Middle East And Africa) https://www.databridgemarketresearch.com/reports/global-induced-pluripotent-stem-cells-market
  • Human Embryonic Stem Cell Market, By Type (Totipotent Stem Cells, Pluripotent Stem Cells, Unipotent Stem Cells), Application (Regenerative Medicine, Stem Cell Biology Research, Tissue Engineering, Toxicology Testing), End User (Research, Clinical Trials, Others), Country (U.S., Canada, Mexico, Germany, Italy, U.K., France, Spain, Netherland, Belgium, Switzerland, Turkey, Russia, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Rest of Asia- Pacific, Brazil, Argentina, Rest of South America, South Africa, Saudi Arabia, UAE, Egypt, Israel, Rest of Middle East & Africa) https://www.databridgemarketresearch.com/reports/global-human-embryonic-stem-cell-market

About Data Bridge Market Research:

An absolute way to forecast what future holds is to comprehend the trend today!

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavours to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Data Bridge is an aftermath of sheer wisdom and experience which was formulated and framed in the year 2015 in Pune.

Data Bridge Market Research has over 500 analysts working in different industries. We have catered more than 40% of the fortune 500 companies globally and have a network of more than 5000+ clientele around the globe. Data Bridge adepts in creating satisfied clients who reckon upon our services and rely on our hard work with certitude. We are content with our glorious 99.9 % client satisfying rate.

Contact Us:

Data Bridge Market Research
US: +1 888 387 2818
UK: +44 208 089 1725
Hong Kong: +852 8192 7475
Email:- corporatesales@databridgemarketresearch.com


Tags

Stem Cell Therapy Market Stem Cell Therapy Stem Cell Therapy Industry Stem Cell Stem Cell Market

Related Links